Index by author

01 December 2018; volume 52, issue 6

A

  1. Abubakar, Ibrahim

    1. Collin, Simon M. et al "Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes." European Respiratory Journal 52.6 (2018): 1801449. Web. 14 June. 2021.

  2. Agusti, Alvar

    1. Agusti, Alvar et al "Inhaled corticosteroids in COPD: friend or foe?." European Respiratory Journal 52.6 (2018): 1801219. Web. 14 June. 2021.

  3. Al-Dabbagh, Yusuf

    1. Suntila, Nelli S.M. et al "A systematic review of clinical trial registration in major respiratory journals 2010–2018." European Respiratory Journal 52.6 (2018): 1801491. Web. 14 June. 2021.

  4. Anderson, Sarah R.

    1. Collin, Simon M. et al "Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes." European Respiratory Journal 52.6 (2018): 1801449. Web. 14 June. 2021.

  5. Antoni, Christian

    1. Raghu, Ganesh et al "SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)." European Respiratory Journal 52.6 (2018): 1801130. Web. 14 June. 2021.

  6. Ariel, Amnon

    1. Suissa, Samy, and Amnon Ariel. "Triple therapy trials in COPD: a precision medicine opportunity." European Respiratory Journal 52.6 (2018): 1801848. Web. 14 June. 2021.

  7. Atieh, Eyad

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 14 June. 2021.

B

  1. Bachert, Claus

    1. Van Crombruggen, Koen et al "Innate lymphoid cells in the upper airways: importance of CD117 and IL-1RI expression." European Respiratory Journal 52.6 (2018): 1800742. Web. 14 June. 2021.

  2. Bajwah, Sabrina

    1. Bajwah, Sabrina et al "Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study." European Respiratory Journal 52.6 (2018): 1801278. Web. 14 June. 2021.

  3. Baldwin, David R.

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  4. Bantubani, Nonkqubela

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 14 June. 2021.

  5. Barber, Clair

    1. Brown, Thomas et al "Randomised controlled trials in severe asthma: selection by phenotype or stereotype." European Respiratory Journal 52.6 (2018): 1801444. Web. 14 June. 2021.

  6. Barco, Stefano

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 14 June. 2021.

  7. Bartlett, Emily C.

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 14 June. 2021.

  8. Beasley, Richard

    1. Shrimanker, Rahul, Richard Beasley, and Ciléin Kearns. "Letting the right one in: evaluating the generalisability of clinical trials." European Respiratory Journal 52.6 (2018): 1802218. Web. 14 June. 2021.

  9. Beckett, Paul

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  10. Bejuit, Raphael

    1. Raghu, Ganesh et al "SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)." European Respiratory Journal 52.6 (2018): 1801130. Web. 14 June. 2021.

  11. Berghmans, Thierry

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  12. Besnard, Valérie

    1. Rotenberg, Cécile et al "Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia." European Respiratory Journal 52.6 (2018): 1801482. Web. 14 June. 2021.

  13. Bhalla, Sanjeev

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 14 June. 2021.

  14. Blum, Torsten Gerriet

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  15. Boucher, Richard C.

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 14 June. 2021.

  16. Boyd, Jeanette

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  17. Boyles, Susan E.

    1. Gentzsch, Martina et al "The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model." European Respiratory Journal 52.6 (2018): 1801133. Web. 14 June. 2021.

  18. Bradding, Peter

    1. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 14 June. 2021.

  19. Brightling, Chris E.

    1. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 14 June. 2021.

  20. Brillet, Pierre-Yves

    1. Rotenberg, Cécile et al "Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia." European Respiratory Journal 52.6 (2018): 1801482. Web. 14 June. 2021.

  21. Brown, Thomas

    1. Brown, Thomas et al "Randomised controlled trials in severe asthma: selection by phenotype or stereotype." European Respiratory Journal 52.6 (2018): 1801444. Web. 14 June. 2021.

  22. Button, Brian

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 14 June. 2021.

C

  1. Calandriello, Lucio

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 14 June. 2021.

  2. Calzetta, Luigino

    1. Cazzola, Mario et al "Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis." European Respiratory Journal 52.6 (2018): 1801586. Web. 14 June. 2021.

  3. Cao, Xuefang

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  4. Cazzola, Mario

    1. Cazzola, Mario et al "Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis." European Respiratory Journal 52.6 (2018): 1801586. Web. 14 June. 2021.

  5. Celli, Bartolome

    1. Agusti, Alvar et al "Inhaled corticosteroids in COPD: friend or foe?." European Respiratory Journal 52.6 (2018): 1801219. Web. 14 June. 2021.

  6. Chalmers, James D.

    1. Suntila, Nelli S.M. et al "A systematic review of clinical trial registration in major respiratory journals 2010–2018." European Respiratory Journal 52.6 (2018): 1801491. Web. 14 June. 2021.

  7. Chauhan, Anoop

    1. Brown, Thomas et al "Randomised controlled trials in severe asthma: selection by phenotype or stereotype." European Respiratory Journal 52.6 (2018): 1801444. Web. 14 June. 2021.

  8. Chen, Xiaoyou

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  9. Chen, Yu

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  10. Cholon, Deborah M.

    1. Gentzsch, Martina et al "The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model." European Respiratory Journal 52.6 (2018): 1801133. Web. 14 June. 2021.

  11. Chotoo, Sunitha

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 14 June. 2021.

  12. Christy, Matthew

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 14 June. 2021.

  13. Collin, Simon M.

    1. Collin, Simon M. et al "Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes." European Respiratory Journal 52.6 (2018): 1801449. Web. 14 June. 2021.

  14. Conradie, Francesca

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 14 June. 2021.

  15. Cosio, Borja G.

    1. Soriano, Joan B., Francesca Polverino, and Borja G. Cosio. "What is early COPD and why is it important?." European Respiratory Journal 52.6 (2018): 1801448. Web. 14 June. 2021.

  16. Cottin, Vincent

    1. Wijsenbeek, Marlies S., Mirjam Kool, and Vincent Cottin. "Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end." European Respiratory Journal 52.6 (2018): 1802111. Web. 14 June. 2021.

  17. Cramer-van der Welle, Christine M.

    1. Cramer-van der Welle, Christine M. et al "Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer." European Respiratory Journal 52.6 (2018): 1801100. Web. 14 June. 2021.

  18. Crestani, Bruno

    1. Raghu, Ganesh et al "SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)." European Respiratory Journal 52.6 (2018): 1801130. Web. 14 June. 2021.

  19. Cui, Wei

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  20. Cunningham, Steve

    1. Cunningham, Steve, Carlee Gilbert, and Nico Schwerk. "The European research collaboration for Children's Interstitial Lung Disease (ChILDEU) ERS Clinical Research Collaboration." European Respiratory Journal 52.6 (2018): 1801855. Web. 14 June. 2021.

  21. Currow, David C.

    1. Bajwah, Sabrina et al "Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study." European Respiratory Journal 52.6 (2018): 1801278. Web. 14 June. 2021.

D

  1. Dale, Katie Dorothy

    1. Dale, Katie Dorothy et al "Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia." European Respiratory Journal 52.6 (2018): 1801218. Web. 14 June. 2021.

  2. Dartevelle, Philippe

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 14 June. 2021.

  3. Davies, Joanna M.

    1. Bajwah, Sabrina et al "Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study." European Respiratory Journal 52.6 (2018): 1801278. Web. 14 June. 2021.

  4. Delcroix, Marion

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 14 June. 2021.

  5. Denholm, Justin Timothy

    1. Dale, Katie Dorothy et al "Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia." European Respiratory Journal 52.6 (2018): 1801218. Web. 14 June. 2021.

  6. de Ruysscher, Dirk K.M.

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  7. Desai, Sujal R.

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 14 June. 2021.

  8. Devaraj, Anand

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 14 June. 2021.

  9. de Vries, Gerard

    1. Collin, Simon M. et al "Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes." European Respiratory Journal 52.6 (2018): 1801449. Web. 14 June. 2021.

  10. Dodd, Pete J.

    1. Dale, Katie Dorothy et al "Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia." European Respiratory Journal 52.6 (2018): 1801218. Web. 14 June. 2021.

E

  1. Ekström, Magnus

    1. Bajwah, Sabrina et al "Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study." European Respiratory Journal 52.6 (2018): 1801278. Web. 14 June. 2021.

  2. Elliott, Scott

    1. Brown, Thomas et al "Randomised controlled trials in severe asthma: selection by phenotype or stereotype." European Respiratory Journal 52.6 (2018): 1801444. Web. 14 June. 2021.

  3. Enwerem, Martin

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 14 June. 2021.

  4. Esperet, Corinne

    1. Raghu, Ganesh et al "SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)." European Respiratory Journal 52.6 (2018): 1801130. Web. 14 June. 2021.

F

  1. Fabbri, Leonardo

    1. Vestbo, Jørgen et al "Inhaled corticosteroid containing combinations and mortality in COPD." European Respiratory Journal 52.6 (2018): 1801230. Web. 14 June. 2021.

  2. Fabbri, Leonardo M.

    1. Agusti, Alvar et al "Inhaled corticosteroids in COPD: friend or foe?." European Respiratory Journal 52.6 (2018): 1801219. Web. 14 June. 2021.

  3. Fadel, Elie

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 14 June. 2021.

  4. Faivre-Finn, Corinne

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  5. Feng, Boxuan

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  6. Ferreira, Hannetjie

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 14 June. 2021.

  7. Fontana, Nicholas C.

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 14 June. 2021.

  8. Forest, M. Gregory

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 14 June. 2021.

  9. Franssen, Frits M.E.

    1. Agusti, Alvar et al "Inhaled corticosteroids in COPD: friend or foe?." European Respiratory Journal 52.6 (2018): 1801219. Web. 14 June. 2021.

G

  1. Galateau-Salle, Françoise

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  2. Gamarra, Fernando

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  3. Gao, Lei

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  4. Garbarine, Ian C.

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 14 June. 2021.

  5. Gentzsch, Martina

    1. Gentzsch, Martina et al "The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model." European Respiratory Journal 52.6 (2018): 1801133. Web. 14 June. 2021.

  6. Gilbert, Carlee

    1. Cunningham, Steve, Carlee Gilbert, and Nico Schwerk. "The European research collaboration for Children's Interstitial Lung Disease (ChILDEU) ERS Clinical Research Collaboration." European Respiratory Journal 52.6 (2018): 1801855. Web. 14 June. 2021.

  7. Giraudier, Stéphane

    1. Rotenberg, Cécile et al "Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia." European Respiratory Journal 52.6 (2018): 1801482. Web. 14 June. 2021.

  8. Goo, Jin Mo

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 14 June. 2021.

  9. Gove, Kerry

    1. Brown, Thomas et al "Randomised controlled trials in severe asthma: selection by phenotype or stereotype." European Respiratory Journal 52.6 (2018): 1801444. Web. 14 June. 2021.

  10. Green, Ruth H.

    1. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 14 June. 2021.

  11. Grigoriu, Bogdan

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  12. Groen, Harry J.M.

    1. Cramer-van der Welle, Christine M. et al "Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer." European Respiratory Journal 52.6 (2018): 1801100. Web. 14 June. 2021.

  13. Guan, Ling

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  14. Guan, Xueling

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  15. Guasconi, Alessandro

    1. Vestbo, Jørgen et al "Inhaled corticosteroid containing combinations and mortality in COPD." European Respiratory Journal 52.6 (2018): 1801230. Web. 14 June. 2021.

H

  1. Habibpour, Mehdi

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 14 June. 2021.

  2. Haldar, Pranabashis

    1. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 14 June. 2021.

  3. Hansen, Niels-Christian G.

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  4. Hantos, Zoltán

    1. Sly, Peter D., and Zoltán Hantos. "The International Collaboration to Improve Respiratory Health in Children (INCIRCLE) ERS Clinical Research Collaboration." European Respiratory Journal 52.6 (2018): 1801867. Web. 14 June. 2021.

  5. Hardavella, Georgia

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 14 June. 2021.
    2. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  6. Hargadon, Beverley

    1. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 14 June. 2021.

  7. Heaney, Liam G.

    1. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 14 June. 2021.

  8. Hill, David B.

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 14 June. 2021.

  9. Holtappels, Gabriele

    1. Van Crombruggen, Koen et al "Innate lymphoid cells in the upper airways: importance of CD117 and IL-1RI expression." European Respiratory Journal 52.6 (2018): 1800742. Web. 14 June. 2021.

  10. Houben, Rein M.G.J.

    1. Dale, Katie Dorothy et al "Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia." European Respiratory Journal 52.6 (2018): 1801218. Web. 14 June. 2021.

  11. Howarth, Peter

    1. Brown, Thomas et al "Randomised controlled trials in severe asthma: selection by phenotype or stereotype." European Respiratory Journal 52.6 (2018): 1801444. Web. 14 June. 2021.

  12. Hughes, Jennifer

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 14 June. 2021.

I

  1. Ismail, Nazir

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 14 June. 2021.

J

  1. Jakobsen, Erik

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  2. Jenkins, David

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 14 June. 2021.

  3. Jin, Qi

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  4. Jones, Thomas

    1. Brown, Thomas et al "Randomised controlled trials in severe asthma: selection by phenotype or stereotype." European Respiratory Journal 52.6 (2018): 1801444. Web. 14 June. 2021.

  5. Jovanovic, Dragana

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

K

  1. Kartoun, Uri

    1. Kartoun, Uri. "Improving the management of spontaneous pneumothorax." European Respiratory Journal 52.6 (2018): 1801857. Web. 14 June. 2021.

  2. Kearns, Ciléin

    1. Shrimanker, Rahul, Richard Beasley, and Ciléin Kearns. "Letting the right one in: evaluating the generalisability of clinical trials." European Respiratory Journal 52.6 (2018): 1802218. Web. 14 June. 2021.

  3. Kim, Nick H.

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 14 June. 2021.

  4. Kissner, William J.

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 14 June. 2021.

  5. Klein, Jeffrey S.

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 14 June. 2021.

  6. Klok, Frederikus A.

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 14 June. 2021.

  7. Klungel, Olaf H.

    1. Cramer-van der Welle, Christine M. et al "Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer." European Respiratory Journal 52.6 (2018): 1801100. Web. 14 June. 2021.

  8. Konsoulova, Assia

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  9. Konstantinides, Stavros V.

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 14 June. 2021.

  10. Kool, Mirjam

    1. Wijsenbeek, Marlies S., Mirjam Kool, and Vincent Cottin. "Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end." European Respiratory Journal 52.6 (2018): 1802111. Web. 14 June. 2021.

  11. Koulouris, Nikolaos G.

    1. Spinou, Arietta, and Nikolaos G. Koulouris. "Current clinical management of smoke inhalation injuries: a reality check." European Respiratory Journal 52.6 (2018): 1802163. Web. 14 June. 2021.

L

  1. Lang, Irene M.

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 14 June. 2021.

  2. Leclercq, Georges

    1. Van Crombruggen, Koen et al "Innate lymphoid cells in the upper airways: importance of CD117 and IL-1RI expression." European Respiratory Journal 52.6 (2018): 1800742. Web. 14 June. 2021.

  3. Leung, Janice M.

    1. Leung, Janice M., and Don D. Sin. "Inhaled corticosteroids in COPD: the final verdict is…." European Respiratory Journal 52.6 (2018): 1801940. Web. 14 June. 2021.

  4. Li, Hengjing

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  5. Li, Xiangwei

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  6. Lindell, Kathleen

    1. Lindell, Kathleen, and Ganesh Raghu. "Palliative care for patients with pulmonary fibrosis: symptom relief is essential." European Respiratory Journal 52.6 (2018): 1802086. Web. 14 June. 2021.

  7. Liu, Jianmin

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  8. Liu, Zisen

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  9. Long, Robert F.

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 14 June. 2021.

  10. Lönnroth, Knut

    1. Collin, Simon M. et al "Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes." European Respiratory Journal 52.6 (2018): 1801449. Web. 14 June. 2021.

M

  1. Ma, Yu

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  2. Maartens, Gary

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 14 June. 2021.

  3. MacMahon, Heber

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 14 June. 2021.

  4. Madani, Michael

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 14 June. 2021.

  5. Markovetz, Matthew R.

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 14 June. 2021.

  6. Martino, Mary E.B.

    1. Gentzsch, Martina et al "The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model." European Respiratory Journal 52.6 (2018): 1801133. Web. 14 June. 2021.

  7. Massard, Gilbert

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  8. Master, Iqbal

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 14 June. 2021.

  9. Matera, Maria Gabriella

    1. Cazzola, Mario et al "Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis." European Respiratory Journal 52.6 (2018): 1801586. Web. 14 June. 2021.

  10. Matsubara, Hiromi

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 14 June. 2021.

  11. Mayer, Eckhard

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 14 June. 2021.

  12. McPhelim, John

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  13. Meert, Anne-Pascale

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  14. Meintjes, Graeme

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 14 June. 2021.

  15. Menzies, Dick

    1. Menzies, Dick, and Anete Trajman. "New short regimens for latent tuberculosis treatment: safety first!." European Respiratory Journal 52.6 (2018): 1802180. Web. 14 June. 2021.

  16. Migliori, Giovanni Battista

    1. Collin, Simon M. et al "Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes." European Respiratory Journal 52.6 (2018): 1801449. Web. 14 June. 2021.

  17. Milroy, Robert

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  18. Mohr, Erika

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 14 June. 2021.

  19. Morales, Daniel R.

    1. Morales, Daniel R.. "Challenges in interpreting trends in testing for α1-antitrypsin deficiency in COPD patients from UK primary care." European Respiratory Journal 52.6 (2018): 1801986. Web. 14 June. 2021.

  20. Mutti, Luciano

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

N

  1. Nair, Arjun

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 14 June. 2021.

  2. Navani, Neal

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 14 June. 2021.

  3. Ndjeka, Norbert

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 14 June. 2021.

  4. Nunes, Hilario

    1. Rotenberg, Cécile et al "Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia." European Respiratory Journal 52.6 (2018): 1801482. Web. 14 June. 2021.

O

  1. Oluyase, Adejoke O.

    1. Bajwah, Sabrina et al "Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study." European Respiratory Journal 52.6 (2018): 1801278. Web. 14 June. 2021.

P

  1. Padanilam, Xavier

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 14 June. 2021.

  2. Paesmans, Marianne

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  3. Pan, Shouguo

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  4. Papi, Alberto

    1. Agusti, Alvar et al "Inhaled corticosteroids in COPD: friend or foe?." European Respiratory Journal 52.6 (2018): 1801219. Web. 14 June. 2021.
    2. Vestbo, Jørgen et al "Inhaled corticosteroid containing combinations and mortality in COPD." European Respiratory Journal 52.6 (2018): 1801230. Web. 14 June. 2021.

  5. Pavord, Ian D.

    1. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 14 June. 2021.

  6. Peake, Michael D.

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  7. Pepke-Zaba, Joanna

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 14 June. 2021.

  8. Peters, Bas J.M.

    1. Cramer-van der Welle, Christine M. et al "Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer." European Respiratory Journal 52.6 (2018): 1801100. Web. 14 June. 2021.

  9. Petruzzelli, Stefano

    1. Vestbo, Jørgen et al "Inhaled corticosteroid containing combinations and mortality in COPD." European Respiratory Journal 52.6 (2018): 1801230. Web. 14 June. 2021.

  10. Polverino, Francesca

    1. Soriano, Joan B., Francesca Polverino, and Borja G. Cosio. "What is early COPD and why is it important?." European Respiratory Journal 52.6 (2018): 1801448. Web. 14 June. 2021.

  11. Porcel, José M.

    1. Porcel, José M.. "Improving the management of spontaneous pneumothorax." European Respiratory Journal 52.6 (2018): 1801918. Web. 14 June. 2021.

  12. Putora, Paul Martin

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

Q

  1. Quinney, Nancy L.

    1. Gentzsch, Martina et al "The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model." European Respiratory Journal 52.6 (2018): 1801133. Web. 14 June. 2021.

R

  1. Rabe, Klaus F.

    1. Agusti, Alvar et al "Inhaled corticosteroids in COPD: friend or foe?." European Respiratory Journal 52.6 (2018): 1801219. Web. 14 June. 2021.

  2. Raghu, Ganesh

    1. Lindell, Kathleen, and Ganesh Raghu. "Palliative care for patients with pulmonary fibrosis: symptom relief is essential." European Respiratory Journal 52.6 (2018): 1802086. Web. 14 June. 2021.
    2. Raghu, Ganesh et al "SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)." European Respiratory Journal 52.6 (2018): 1801130. Web. 14 June. 2021.

  3. Ribeiro, Carla M.P.

    1. Gentzsch, Martina et al "The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model." European Respiratory Journal 52.6 (2018): 1801133. Web. 14 June. 2021.

  4. Rich, Anna L.

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  5. Richeldi, Luca

    1. Raghu, Ganesh et al "SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)." European Respiratory Journal 52.6 (2018): 1801130. Web. 14 June. 2021.

  6. Rogliani, Paola

    1. Cazzola, Mario et al "Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis." European Respiratory Journal 52.6 (2018): 1801586. Web. 14 June. 2021.

  7. Romero, Rodolfo

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 14 June. 2021.

  8. Rotenberg, Cécile

    1. Rotenberg, Cécile et al "Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia." European Respiratory Journal 52.6 (2018): 1801482. Web. 14 June. 2021.

  9. Rubin, Bruce K.

    1. Rubin, Bruce K., and David J. Thornton. "Dropping acid: why is cystic fibrosis mucus abnormal?." European Respiratory Journal 52.6 (2018): 1802057. Web. 14 June. 2021.

S

  1. Schaefer-Prokop, C.M.

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 14 June. 2021.

  2. Scherpereel, Arnaud

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  3. Schnippel, Kathryn

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 14 June. 2021.

  4. Schramel, Franz M.N.H.

    1. Cramer-van der Welle, Christine M. et al "Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer." European Respiratory Journal 52.6 (2018): 1801100. Web. 14 June. 2021.

  5. Schwerk, Nico

    1. Cunningham, Steve, Carlee Gilbert, and Nico Schwerk. "The European research collaboration for Children's Interstitial Lung Disease (ChILDEU) ERS Clinical Research Collaboration." European Respiratory Journal 52.6 (2018): 1801855. Web. 14 June. 2021.

  6. Sculier, Jean-Paul

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  7. Scuri, Mario

    1. Vestbo, Jørgen et al "Inhaled corticosteroid containing combinations and mortality in COPD." European Respiratory Journal 52.6 (2018): 1801230. Web. 14 June. 2021.

  8. Seo, Joon-Beom

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 14 June. 2021.

  9. Shen, Fei

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  10. Shrimanker, Rahul

    1. Shrimanker, Rahul, Richard Beasley, and Ciléin Kearns. "Letting the right one in: evaluating the generalisability of clinical trials." European Respiratory Journal 52.6 (2018): 1802218. Web. 14 June. 2021.
    2. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 14 June. 2021.

  11. Sin, Don D.

    1. Leung, Janice M., and Don D. Sin. "Inhaled corticosteroids in COPD: the final verdict is…." European Respiratory Journal 52.6 (2018): 1801940. Web. 14 June. 2021.

  12. Singh, Dave

    1. Agusti, Alvar et al "Inhaled corticosteroids in COPD: friend or foe?." European Respiratory Journal 52.6 (2018): 1801219. Web. 14 June. 2021.
    2. Vestbo, Jørgen et al "Inhaled corticosteroid containing combinations and mortality in COPD." European Respiratory Journal 52.6 (2018): 1801230. Web. 14 June. 2021.

  13. Singh, Nalini

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 14 June. 2021.

  14. Sly, Peter D.

    1. Sly, Peter D., and Zoltán Hantos. "The International Collaboration to Improve Respiratory Health in Children (INCIRCLE) ERS Clinical Research Collaboration." European Respiratory Journal 52.6 (2018): 1801867. Web. 14 June. 2021.

  15. Smith, Alexandria

    1. Suntila, Nelli S.M. et al "A systematic review of clinical trial registration in major respiratory journals 2010–2018." European Respiratory Journal 52.6 (2018): 1801491. Web. 14 June. 2021.

  16. Soriano, Joan B.

    1. Soriano, Joan B., Francesca Polverino, and Borja G. Cosio. "What is early COPD and why is it important?." European Respiratory Journal 52.6 (2018): 1801448. Web. 14 June. 2021.
    2. Soriano, Joan B.. "Challenges in interpreting trends in testing for α1-antitrypsin deficiency in COPD patients from UK primary care." European Respiratory Journal 52.6 (2018): 1802064. Web. 14 June. 2021.

  17. Soubrane, Christina

    1. Raghu, Ganesh et al "SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)." European Respiratory Journal 52.6 (2018): 1801130. Web. 14 June. 2021.

  18. Spinou, Arietta

    1. Spinou, Arietta, and Nikolaos G. Koulouris. "Current clinical management of smoke inhalation injuries: a reality check." European Respiratory Journal 52.6 (2018): 1802163. Web. 14 June. 2021.

  19. Subotic, Dragan R.

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  20. Suissa, Samy

    1. Suissa, Samy, and Amnon Ariel. "Triple therapy trials in COPD: a precision medicine opportunity." European Respiratory Journal 52.6 (2018): 1801848. Web. 14 June. 2021.

  21. Suntila, Nelli S.M.

    1. Suntila, Nelli S.M. et al "A systematic review of clinical trial registration in major respiratory journals 2010–2018." European Respiratory Journal 52.6 (2018): 1801491. Web. 14 June. 2021.

  22. Sverzellati, Nicola

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 14 June. 2021.

T

  1. Tanash, Hanan

    1. Bajwah, Sabrina et al "Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study." European Respiratory Journal 52.6 (2018): 1801278. Web. 14 June. 2021.

  2. Tarran, Robert

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 14 June. 2021.

  3. Taveirne, Sylvie

    1. Van Crombruggen, Koen et al "Innate lymphoid cells in the upper airways: importance of CD117 and IL-1RI expression." European Respiratory Journal 52.6 (2018): 1800742. Web. 14 June. 2021.

  4. te Riele, Julian

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 14 June. 2021.

  5. Thornton, David J.

    1. Rubin, Bruce K., and David J. Thornton. "Dropping acid: why is cystic fibrosis mucus abnormal?." European Respiratory Journal 52.6 (2018): 1802057. Web. 14 June. 2021.

  6. Trajman, Anete

    1. Menzies, Dick, and Anete Trajman. "New short regimens for latent tuberculosis treatment: safety first!." European Respiratory Journal 52.6 (2018): 1802180. Web. 14 June. 2021.

  7. Trauer, James McCracken

    1. Dale, Katie Dorothy et al "Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia." European Respiratory Journal 52.6 (2018): 1801218. Web. 14 June. 2021.

V

  1. Valeyre, Dominique

    1. Rotenberg, Cécile et al "Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia." European Respiratory Journal 52.6 (2018): 1801482. Web. 14 June. 2021.

  2. Van Crombruggen, Koen

    1. Van Crombruggen, Koen et al "Innate lymphoid cells in the upper airways: importance of CD117 and IL-1RI expression." European Respiratory Journal 52.6 (2018): 1800742. Web. 14 June. 2021.

  3. van de Garde, Ewoudt M.W.

    1. Cramer-van der Welle, Christine M. et al "Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer." European Respiratory Journal 52.6 (2018): 1801100. Web. 14 June. 2021.

  4. Van Schil, Paul

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 14 June. 2021.

  5. Variava, Ebrahim

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 14 June. 2021.

  6. Vestbo, Jørgen

    1. Agusti, Alvar et al "Inhaled corticosteroids in COPD: friend or foe?." European Respiratory Journal 52.6 (2018): 1801219. Web. 14 June. 2021.
    2. Vestbo, Jørgen et al "Inhaled corticosteroid containing combinations and mortality in COPD." European Respiratory Journal 52.6 (2018): 1801230. Web. 14 June. 2021.

  7. Vezzoli, Stefano

    1. Vestbo, Jørgen et al "Inhaled corticosteroid containing combinations and mortality in COPD." European Respiratory Journal 52.6 (2018): 1801230. Web. 14 June. 2021.

W

  1. Walsh, Simon L.F.

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 14 June. 2021.

  2. Wang, Dakuan

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  3. Wardlaw, Andrew J.

    1. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 14 June. 2021.

  4. Wells, Athol U.

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 14 June. 2021.

  5. Wijsenbeek, Marlies S.

    1. Wijsenbeek, Marlies S., Mirjam Kool, and Vincent Cottin. "Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end." European Respiratory Journal 52.6 (2018): 1802111. Web. 14 June. 2021.

  6. Wung, Peter

    1. Raghu, Ganesh et al "SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)." European Respiratory Journal 52.6 (2018): 1801130. Web. 14 June. 2021.

X

  1. Xin, Henan

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

Y

  1. Yan, Jiaoxia

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  2. Yancey, Steve

    1. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 14 June. 2021.

Z

  1. Zenner, Dominik

    1. Collin, Simon M. et al "Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes." European Respiratory Journal 52.6 (2018): 1801449. Web. 14 June. 2021.

  2. Zhang, Haoran

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  3. Zhang, Zongde

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.

  4. Zhou, Xinhua

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 14 June. 2021.
Back to top
European Respiratory Journal: 52 (6)

Search Within This Issue

Jump to

Manage Table of content Alerts